Neuregulin-1β regulation of embryonic endothelial progenitor cell survival

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 4, 2011, Pages

  Safa, Radwan N ^a   Peng, Xu Yang ^b   Pentassuglia, Laura ^b   Lim, Chee Chew ^b   Lamparter, Mathias ^b   Silverstein, Cheri ^b   Walker, Jeremy ^b   Chen, Billy ^a   Geisberg, Carrie ^b   Hatzopoulos, Antonis K ^b   Sawyer, Douglas B ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Erbb2; Erbb3

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEU DIFFERENTIATION FACTOR; NEU DIFFERENTIATION FACTOR 1BETA; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD; BONE MARROW; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HEART MUSCLE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; TRANSCRIPTION INITIATION;

ANIMALS; BETA CATENIN; BONE MARROW CELLS; CELL SURVIVAL; CELLS, CULTURED; EMBRYONIC STEM CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; NEUREGULIN-1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3;

EID: 79955072413     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01104.2009     Document Type: Article

References (46)

1. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, Tarnok A, Gielen S, Emmrich F, Schuler G, Hambrecht R. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 24: 684-690, 2004.
2. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287: C572-C579, 2004.
3. S6K, and MEK-MAPK-RSK. Am J Physiol Heart Circ Physiol 277: H2026-H2037, 1999.
4. Bersell KS, Arab B, Haring B, Kuhn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138: 257-270, 2009.
5. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83: 59-115, 2003.
6. Carpenter G. ErbB-4: mechanism of action and biology. Exp Cell Res 284: 66-77, 2003.
7. Choi JH, Hur J, Yoon CH, Kim JH, Lee CS, Youn SW, Oh IY, Skurk C, Murohara T, Park YB, Walsh K, Kim HS. Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. J Biol Chem 279: 49430-49438, 2004.
8. Cote G, Miller T, Lebrasseur N, Kuramochi Y, Sawyer DB. Neuregu-lin-1alpha and beta isoform expression in cardiac microvascular endothe-lial cells and function in cardiac myocytes in vitro. Exp Cell Res 311: 135-146, 2005.
9. De Falco E, Porcelli D, Torella A, Straino S, Iachininoto M, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi M, Pesce M. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482, 2004.
10. Fingar DC, Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23: 3151-3171, 2004.
11. Flores A, Mallon B, Matsui T, Ogawa W, Rosenzweig A, Okamoto T, Macklin W. Akt-mediated survival of oligodendrocytes induced by neu-regulins. J Neurosci 20: 7622-7630, 2000.
12. Fukazawa R, Miller T, Kuramochi Y, Frantz S, Kim Y, Marchionni M, Kelly RA, Sawyer DB. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol 35: 1473-1479, 2003.
13. Hatzopoulos A, Folkman J, Vasile E, Eiselen G, Rosenberg R. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125: 1457-1468, 1998.
14. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23: 1185-1189, 2003.
15. Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T, Losordo DW. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 111: 1114-1120, 2005.
16. Izumi Y, Xu L, Di Tomaso E, Fukumura D, Jain R. Tumour biology: Herceptin acts as an anti-angiogenic cocktail. Nature 416: 279-280, 2002.
17. Junttila T, Sundvall M, Maatta J, Elenius K. Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med 10: 304-310, 2000.
18. Kupatt C, Horktkotte J, Vlastos G, Pfosser A, Lebherz C, Semisch M, Thalgott M, Buttner K, Browarzyk C, Mages J, Hoffman R, Deten A, Lamparter M, Muller F, Beck H, Buning H, Boekstegers P, Hatzo-Poulos A. Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J 19: 1576- 1578, 2005.
19. Kupatt C, Hinkerl R, Lamparter M, von Bruhl M, Pohl T, Horskotte J, Beck H, Muller S, Delker S, Gildehaus F, Buning H, Hatzopoulos A, Boekstegers P. Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase. Circulation 112: I117-I122, 2005.
20. Kuramochi Y, Cote G, Guo X, Lebrasseur N, Cui L, Liao R, Sawyer DB. Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J Biol Chem 279: 51141-51147, 2004.
21. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109: 220-226, 2004.
22. Laughner E, Taghavi P, Chiles K, Mahon P, Semenza G. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endo-thelial growth factor expression. Mol Cell Biol 21: 3995-4004, 2001.
23. Lebrasseur N, Cote G, Miller T, Fielding R, Sawyer DB. Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle. Am J Physiol Cell Physiol 284: C1149-C1155, 2003.
24. Lemmens K, Segers V, Demold M, De Keulenaer G. Role of neuregu-lin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk. J Biol Chem 281: 19469-19477, 2006.
25. Li Y, Tennekoon G, Birnbaum M, Marchionni M, Rutkowski J. Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival. Mol Cell Neurosci 17: 761-767, 2001.
26. Liu J, Kern JA. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. Am J Respir Cell Mol Biol 27: 306-313, 2002.
27. Lok J, Sardi S, Guo S, Besancon E, Ha D, Rosell A, Kim W, Corfas G, Lo E. Neuregulin-1 signaling in brain endothelial cells. J Cereb Blood Flow Metab 29: 39-43, 2009.
28. Miriuka S, Rao V, Peterson M, Tumiati L, Delgado D, Mohan R, Ramzy D, Stewart D, Ross H, Waddell T. mTOR inhibition induces endothelial progenitor cell death. Am J Transplant 6: 2069-2079, 2006.
29. Moondra V, Sarma S, Buxton T, Safa R, Cote G, Storerm T, Lebras-seur N, Sawyer DB. Serum neuregulin-1beta as a biomarker of cardiovascular fitness. Open Biomark J 2: 1-5, 2009.
30. Pentassuglia L, Graf M, Lane H, Kuramochi Y, Cote G, Timolati F, Sawyer DB, Zuppinger C, Suter T. Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes. Exp Cell Res 315: 1302-1312, 2009.
31. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-712, 2003.
32. Rehman J, Li J, Orschell C, March K. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003.
33. Rehman J, Li J, Pravathaneni L, Karlsson G, Panchal V, Temm C, Mahenthiran J, March K. Exercise acutely increases circulating endo-thelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 43: 2314-2318, 2004.
34. Ribatti D. The involvement of endothelial progenitor cells in tumor angiogenesis. J Cell Mol Med 8: 294-300, 2004.
35. Russell KS, Stern D, Polverini P, Bender J. Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis. Am J Physiol Heart Circ Physiol 277: H2205-H2211, 1999.
36. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Piller J, Laufs K, Ghaeni L, Milosevic M, Bohm M, Nickenig G. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107: 3059-3065, 2003.
37. Takahashi T, Kalka C, Masuda H, Silver M, Kearney M, Magner M, Isner J, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999.
38. Urbich C, Aicher A, Heeschen C, Dernbach E, Hormann W, Zeiher A, Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39: 733-742, 2005.
39. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engel-hardt B, Vestweber D, Hatzopoulos A. Multistep nature of microvascu-lar recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197: 1755-1765, 2003.
40. Xiong S, Grijalve R, Zhang L, Nguyen N, Posters P, Pollock R, Yu D. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endo-thelial cell migration. Cancer Res 61: 1727-1732, 2001.
41. Yang C, Klein E, Assoian R, Kazanietz M. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1. Biochem J 410: 167-175, 2008.
42. Yang Z, Wang J, Chen L, Luo C, Tang A, Tao J. Acute exercise-induced nitric oxide production contributes to upregulation of circulating endothelial progenitor cells in healthy subjects. J Hum Hypertens 21: 452-460, 2007.
43. Yen L, Benilmame N, Nie Z, Xiao D, Wang T, Al Moustafa A, Esumi H, Milanini J, Hynes N, Pages G, Alaoui-Jamali M. Differential regulation of tumor angiogenesis by distinct ErbB homo- and het-erodimers. Mol Biol Cell 13: 4029-4044, 2002.
44. Yin T, Ma X, Zhao L, Cheng K, Wang H. Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. Cell Res 18: 792-799, 2008.
45. Young PP, Vaughan DE, Hatzopoulos AK. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 49: 421-429, 2007.
46. Zhao YY, Sawyer D, Baliga R, Opel D, Han X, Marchionni M, Kelly R. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 273: 10261-10269, 1998.